These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 33850297)
1. A Decade of Pharmacogenetic Studies in Jordan: A Systemic Review. Yehya A; Altaany Z Pharmacogenomics J; 2021 Oct; 21(5):543-550. PubMed ID: 33850297 [TBL] [Abstract][Full Text] [Related]
2. Expanding role of pharmacogenomics in the management of cardiovascular disorders. Yip VL; Pirmohamed M Am J Cardiovasc Drugs; 2013 Jun; 13(3):151-62. PubMed ID: 23579966 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee. Vassy JL; Stone A; Callaghan JT; Mendes M; Meyer LJ; Pratt VM; Przygodzki RM; Scheuner MT; Wang-Rodriguez J; Schichman SA; Genet Med; 2019 Feb; 21(2):382-390. PubMed ID: 29858578 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of clopidogrel and warfarin in the treatment of cardiovascular diseases: an overview of reviews. de Lara DV; de Melo DO; Araújo Silva LC; Gonçalves TS; Júnior Lima Santos PC Pharmacogenomics; 2022 May; 23(7):443-452. PubMed ID: 35380455 [TBL] [Abstract][Full Text] [Related]
5. Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies. Holmes MV; Shah T; Vickery C; Smeeth L; Hingorani AD; Casas JP PLoS One; 2009 Dec; 4(12):e7960. PubMed ID: 19956635 [TBL] [Abstract][Full Text] [Related]
6. Genetic Analysis of Pharmacogenomic VIP Variants of ABCB1, VDR and TPMT Genes in an Ethnically Isolated Population from the North Caucasus Living in Jordan. Al-Eitan LN; Al-Maqableh HW; Mohammad NN; Hakooz NM; Dajani RB Curr Drug Metab; 2020; 21(4):307-317. PubMed ID: 32368972 [TBL] [Abstract][Full Text] [Related]
7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic testing-guided treatment for oncology: an overview of reviews. de Lara DV; de Melo DO; Kawakami DY; Gonçalves TS; Santos PC Pharmacogenomics; 2022 Aug; 23(13):739-748. PubMed ID: 36001087 [TBL] [Abstract][Full Text] [Related]
9. Development of nursing research in Jordan (1986-2012). Khalaf I Int Nurs Rev; 2013 Dec; 60(4):461-8. PubMed ID: 24251938 [TBL] [Abstract][Full Text] [Related]
10. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Owen RP; Altman RB; Klein TE Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates. Al-Mahayri ZN; Khasawneh LQ; Alqasrawi MN; Altoum SM; Jamil G; Badawi S; Hamza D; George L; AlZaabi A; Ouda H; Al-Maskari F; AlKaabi J; Patrinos GP; Ali BR Hum Genomics; 2022 Sep; 16(1):42. PubMed ID: 36154845 [TBL] [Abstract][Full Text] [Related]
15. The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future. Ndadza A; Thomford NE; Mukanganyama S; Wonkam A; Ntsekhe M; Dandara C OMICS; 2019 Mar; 23(3):152-166. PubMed ID: 30883300 [TBL] [Abstract][Full Text] [Related]
16. Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendations. Luzum JA; Cheung JC Pharmacogenomics; 2018 Oct; 19(15):1203-1216. PubMed ID: 30196751 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial. Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643 [TBL] [Abstract][Full Text] [Related]
18. Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort. Shin J; Cao D Pharmacogenomics; 2011 Jan; 12(1):125-34. PubMed ID: 21174627 [TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions. Plumpton CO; Roberts D; Pirmohamed M; Hughes DA Pharmacoeconomics; 2016 Aug; 34(8):771-93. PubMed ID: 26984520 [TBL] [Abstract][Full Text] [Related]